Provider of interface of chemistry, biotechnology and materials intended to help turn technology into market ready products. The company's interface of chemistry, biotechnology and materials collaborate to identify alternate approaches and solve complex problems provide preclinical contract research organization services to extend the research and development by solving problems creatively and collaboratively, enabling companies and its research and development team to efficiently advance innovation and address untapped markets.
In 2022, iFyber revenue run rate hit $1.5M in revenue.
iFyber hit $1.5M in revenue in 2021
iFyber launched in 2008 with $0 revenue
iFyber Funding History
Why are so many SaaS founders taking money from Founderpath.com instead of VC`s?
iFyber has 21 total employees and 1 sales reps that carry a quota.
Total team size
Greg joined iFyber as president in 2016 and is responsible for providing strategic leadership to the organization and creating and implementing processes supporting our core mission. He brings over 15 years of industry experience working with a range of companies, from medical device start-ups to mature established organizations. With a strong cross-functional background and understanding of the product development process, Greg has developed and executed the business and development plans of large multi-stakeholder projects for both medical device and applied market technologies.